GtoPdb Ligand ID: 7373

AlprolixTM is an approved drug (FDA (2014))
Comment: AlprolixTM is a recombinant fusion protein combining the peptide for coagulation factor IX with an antibody Fc domain. The presence of the Fc domain increases protein half-life and extends the drug's therapeutic window.
Compound class Peptide or derivative
Approved drug? Yes (FDA (2014))
Database Links
GtoPdb PubChem SID 178103945